Osmium absorption after osmium tetroxide skin and eye exposure.

acetone chemical injury electron microscopy exposure hereditary haemochromatosis osmium tetroxide

Journal

Basic & clinical pharmacology & toxicology
ISSN: 1742-7843
Titre abrégé: Basic Clin Pharmacol Toxicol
Pays: England
ID NLM: 101208422

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 06 05 2020
revised: 28 05 2020
accepted: 02 06 2020
pubmed: 12 6 2020
medline: 24 8 2021
entrez: 12 6 2020
Statut: ppublish

Résumé

Osmium tetroxide is a strong oxidizing agent used in electron microscopy. Eye exposure may cause severe burns, and after inhalation or ingestion damage to the respiratory or gastrointestinal tract occurs. Exposure to osmium and its compounds is extremely rare. We present a case of a 32-year-old female stained by 9 mL of 2% osmium tetroxide in acetone during an accident in the laboratory, with rare dermal and ocular findings. Due to lack of data in toxicological databases and the absence of antidote, the therapy was symptomatic. Osmium was detected in serum 19 hours later (0.22 μg/L) and in urine during the 15-hour collection (three samples-7.05, 1.65 and 8.45 μg/L). In blood serum on admission, after 1 and 2 days after exposure, the levels of iron (28.2, 39.8 and 50.5 μmol/L; reference range 5.8-34.5 μmol/L) and transferrin receptor/ferritine were elevated. To our knowledge, this is the first paper documenting a significant absorption from the skin and potentially from the eye conjunctiva, based on serum and urine analysis. The relationship between increased iron in blood and exposure has not been described yet, and the mechanism remains unknown. The patient is being followed up for the unknown long-term effects.

Identifiants

pubmed: 32524772
doi: 10.1111/bcpt.13450
doi:

Substances chimiques

Osmium Tetroxide P40W033BGM

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

429-433

Subventions

Organisme : Charles University in Prague
ID : P25/1LF
Organisme : Charles University in Prague
ID : P29/1LF

Informations de copyright

© 2020 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). Published by John Wiley & Sons Ltd.

Références

Toxbase. Osmium. (2018). https://www.toxbase.org. Accessed April 1, 2020.
JoDrugs. Osmium tetroxide (2020). http://www.jodrugs.com/toxicologies/3241-osmium-tetroxide.aspx. Accessed April 1, 2020.
Micromedex. Osmium Tetroxide (2019). https://www.micromedexsolutions.com. Accessed April 1, 2020.
Mitchell N, Laurin C, Shepard N. The effect of osmium tetroxide and nitrogen mustard on normal articular cartilage. J Bone Joint Surg. 1973;55:814-821.
Makarovsky I, Markel G, Hoffman A, et al. Osmium tetroxide: a new kind of weapon. Isr Med Assoc J. 2007;9:750-752.
Ligon JJ, Abraham JL, Boyd AS. Traumatic osmium tetroxide inoculation. J Am Acad Dermatol. 2001;45:949-952.
Oustamanolakis P, Koutroubakis IE, Messaritakis I, Niniraki M, Kouroumalis EA. Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study. Ann Gastroenterol. 2011;24(2):108-114.
Honkanen E, Törnroth T, Pettersson E, Skrifvars B. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature. Clin Nephrol. 1987;27(2):87-93.
Baxter JP, Aw TC, Cockcroft A, Durrington P, Harrington JM. Hunter’s Diseases of Occupation. 10th edn. London, UK: Taylor & Francis CRC Press; 2010.
Barton JC, Edwards CQ. HFE Hemochromatosis. 2000 Apr 3 [Updated 2018 Dec 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington Seattle; 1993-2020.

Auteurs

Natalie Friedova (N)

Internal Department, Third Faculty of Medicine Charles University, Thomayer Hospital, Prague, Czech Republic.

Daniela Pelclova (D)

Toxicological Information Centre, Department of Occupational Medicine, First Faculty of Medicine, Charles University, General University Hospital Prague, Prague, Czech Republic.

Nikola Obertova (N)

Toxicological Information Centre, Department of Occupational Medicine, First Faculty of Medicine, Charles University, General University Hospital Prague, Prague, Czech Republic.

Karel Lach (K)

Institute of Public Health Ostrava, Ostrava, Czech Republic.

Katerina Kesslerova (K)

Ophthalmological Department, Thomayer Hospital, Prague, Czech Republic.

Pavel Kohout (P)

Internal Department, Third Faculty of Medicine Charles University, Thomayer Hospital, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH